Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Oncogene
|
March 16, 2002
Cdc6 requires anchorage for its expression
Shigeki Jinno, Mika Yageta, Akihisa Nagata, et al.
International Journal of Hematology
|
January 29, 2015
Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients
Akihisa Nagata, Naohiro Sekiguchi, Miwa Kurimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
January 5, 2016
[Achievement of deep molecular response in an elderly chronic myeloid leukemia patient intolerant to imatinib and nilotinib]
Miwa Kurimoto, Akihisa Nagata, Naohiro Sekiguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 16, 2011
[Significance of bortezomib and dexamethasone therapy for multiple myeloma showing a serum creatinine level above 2 mg/dl]
Naohiro Sekiguchi, Naoki Takezako, Mitsuhiro Haga, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
January 16, 2014
Bortezomib, dexamethasone, and high-dose melphalan as conditioning for stem cell transplantation in young Japanese multiple myeloma patients: a pilot study
Naoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, et al.
Internal Medicine (Tokyo, Japan)
|
November 2, 2011
Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapy
Naohiro Sekiguchi, Naoki Takezako, Akihisa Nagata, et al.
International Journal of Hematology
|
February 6, 2014
Impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy
Naohiro Sekiguchi, Kaori Ootsubo, Miyuki Wagatsuma, et al.
Cellular & Molecular Immunology
|
August 28, 2012
Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells
Akihisa Nagata, Naoki Takezako, Hiroyuki Tamemoto, et al.
Thrombosis Research
|
May 3, 2015
Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy
Naoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, et al.
Biomed Research International
|
November 8, 2018
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion
Naohiro Sekiguchi, Junko Nomoto, Akihisa Nagata, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Oncogene
|
March 16, 2002
Cdc6 requires anchorage for its expression
Shigeki Jinno, Mika Yageta, Akihisa Nagata, et al.
International Journal of Hematology
|
January 29, 2015
Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients
Akihisa Nagata, Naohiro Sekiguchi, Miwa Kurimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
January 5, 2016
[Achievement of deep molecular response in an elderly chronic myeloid leukemia patient intolerant to imatinib and nilotinib]
Miwa Kurimoto, Akihisa Nagata, Naohiro Sekiguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 16, 2011
[Significance of bortezomib and dexamethasone therapy for multiple myeloma showing a serum creatinine level above 2 mg/dl]
Naohiro Sekiguchi, Naoki Takezako, Mitsuhiro Haga, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
January 16, 2014
Bortezomib, dexamethasone, and high-dose melphalan as conditioning for stem cell transplantation in young Japanese multiple myeloma patients: a pilot study
Naoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, et al.
Internal Medicine (Tokyo, Japan)
|
November 2, 2011
Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapy
Naohiro Sekiguchi, Naoki Takezako, Akihisa Nagata, et al.
International Journal of Hematology
|
February 6, 2014
Impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy
Naohiro Sekiguchi, Kaori Ootsubo, Miyuki Wagatsuma, et al.
Cellular & Molecular Immunology
|
August 28, 2012
Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells
Akihisa Nagata, Naoki Takezako, Hiroyuki Tamemoto, et al.
Thrombosis Research
|
May 3, 2015
Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy
Naoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, et al.
Biomed Research International
|
November 8, 2018
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion
Naohiro Sekiguchi, Junko Nomoto, Akihisa Nagata, et al.
Page
of 2